The Accordion™ stone management device is a hydrophilic microcatheter-based tool that blocks stone migration. This instrument has been described for use during ureteroscopy to prevent retropulsion of stone fragments. We used this device during percutaneous nephrolithotomy (PCNL) in 30 patients to prevent antegrade migration of stone fragments (group 1), and find that the device is easily inserted and deployed, preventing antegrade stone fragment migration in all but one patient. When compared with 30 patients who were undergoing PCNL without the Accordion device (group 2), our results suggest that the device prevents antegrade stone fragment migration during PCNL, permits targeting larger stones, reduces the use of ureteral stents, and facilitates tubeless procedures. The Accordion device has proven to be a valuable time and morbidity-saving adjunct to PCNL at our institution.
Introduction
T HE ACCORDION™ stone management device (Percsys, Mountain View, CA) is a hydrophyllic coated, microcatheter-based tool composed of a coaxial 0.038 inch guidewire with a floppy tip and a distal multifold film. When it is deployed by coaxial retraction of the inner core of the coaxial wire, it "accordions" to a 7-mm or 10-mm wide device that blocks stone migration and provides the utility of a basket during stone fragment removal.
Previously, the device was described to track easily past a ureteral stone (before deployment) and to prevent retrograde stone fragment migration during ureteroscopy (after deployment) 1 and with laser lithotripsy. 2 The device has also been described to remain functional after holmium:yttriumaluminum-garnet laser contact, despite multiple holes in the occlusive film segment. 3 Once in position, the occlusion conforms to the shape of the ureter, unlike basket or coil devices. The occlusion allows use of irrigation during stone fragmentation while preventing retrograde migration of stone fragments to the kidney. We tested the device during percutaneous nephrolithotomy (PCNL) to evaluate if it prevents antegrade stone fragment migration down the ureter during PCNL.
Patients and Methods
We retrospectively reviewed the Columbia University PCNL database to evaluate stone characteristics and outcomes of 30 patients who underwent PCNL with the Accordion device (group 1) between December 2007 and July 2008 (Table 1) . For comparison, we also included the stone characteristics and outcomes of 30 patients who underwent PCNL without the Accordion device (group 2) from January 2007 to December 2007, the period before availability of the Accordion device (Table 1) . Stone characteristics were identified using either CT (if available) or abdominal radiography. The mean age and gender of group 1 and group 2 patients were similar (52 and 51 years, respectively) ( Table 1 ). All procedures were conducted by a single surgeon (MG). The PCNL protocol used has been described previously. 4 
Technique
The Accordion was used in 30 patients with renal stones who underwent PCNL. The patient was placed in the supine position and, using a 17F flexible cystoscope, a 5F ureteral catheter was placed retrograde into the collecting system to opacify and dilate the system for later access. Next, the Accordion was inserted via the working channel of the flexible cystoscope and placed retrograde to the level of the ureteropelvic junction (UPJ) (Figs. 1 and 2 ). It was then deployed in the proximal ureter. After the cystoscope was removed, the device was tied with silk suture to the ureteral catheter and the Foley catheter to prevent it from migrating. After the patient was placed in the prone position and percutaneous access was achieved, PCNL was carried out in standard fashion (Fig. 2) .
Ultrasonic lithotripsy was used almost exclusively, because it allows excellent stone fragmentation and removal. 
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FIG. 1.
Accordion™ device in packaging (left), before retraction of coaxial inner core ("accordion") (center) deployed ("accordion" position), after retraction of coaxial inner core (right).
Rarely, for very hard calculi, pneumatic lithotripsy was used.
After PCNL completion and removal of all stone fragments, the device was removed from the flank with graspers through the nephroscope. Drainage tubes and ureteral stents were then appropriately placed as deemed necessary by the operating team.
When possible, a tubeless procedure without a nephrostomy tube was performed, and an open-ended catheter or reversed Polaris™ loop stent (Boston Scientific, Natick, MA) was left to drain the renal collecting system and to allow the nephrostomy tract to seal. The ureteral catheter or stent was removed within 23 hours, and the patient was discharged without tubes, stents, or stones.
Results
The Accordion was successfully placed in all patients and prevented antegrade stone fragment migration in all but one patient. In 29 of 30 patients, the occlusive seal provided by the Accordion prevented stone migration down the ureter (Figs. 3 and 4) . Fragments in the renal pelvis were easily extracted with ultrasound lithotripsy and suction without stone migration, even in patients with complete staghorn calculi (largest diameter 4.7 cm) of various compositions (Tables 1 and 2). In the single case of stone migration, a 7-mm Accordion device was used in a dilated ureter and 2 to 3 small fragments passed into the ureter. These had to be removed via flexible ureteroscopy. Mean stone size (based on largest dimension) was 2.52 cm (group 1) compared with 2.01 cm (group 2) (P ϭ 0.067).
In group 1, postoperative ureteral stents were placed in 13 of 30 patients, and a tubeless procedure was used in 18 of 30 patient. When compared with group 2, postoperative ureteral stents were placed in 17 of 30 patients, and a tubeless procedure was used in 15 of 30 patients. Among tube-
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FIG. 2. Fluoroscopic image of Accordion™ device deployed at the ureteropelvic junction
. A 5F open-ended ureteral catheter is adjacent to Accordion™ Nephroscope is in place via percutaneous access.
FIG. 3.
Accordion™ device deployed at the ureteropelvic junction, preventing anetgrade migration of small stone fragment.
less procedures, 6 of 18 patients in group 1 had a ureteral stent placed, while 6 of 15 patients in group 2 had a ureteral stent placed. When excluding patients with UPJ junction obstruction or ureteral stricture, 9 of 22 patients had a ureteral stent in group 1, while 9 of 17 patients had a ureteral stent in group 2. Among those with tubeless procedures, 3 of 14 had ureteral stents in group 1, while 3 of 9 patients had ureteral stents in group 2. The requirement for ureteral stents was equivalent in patients who had nephrostomy tubes placed (six of eight patients in each group had a ureteral stent placed). While there was a trend for fewer postoperative ureteral stents and more frequent tubeless procedures in patients in group 1 than in group 2, the difference in stent usage and tubeless procedures between groups was not statistically significant using the chi-square test.
Stone compositions of the two groups were similar, most commonly calcium phosphate (41%) in group 1 and calcium oxalate monohydrate (43%) in group 2 ( Table 2) . Operative time was shorter in group 1 (114 minutes) than in group 2 (139 minutes) and trended toward statistical significance (P ϭ 0.12). Stone location between groups was similar in terms of laterality, but 20 of 30 patients in group 1 had complete staghorn calculi compared with 8 of 30 in group 2 ( Table 2) . Length of hospital stay in group 1 compared with group 2 was similar (1.73 days and 1.37 days, respectively) (P ϭ 0.35).
Role in Urologic Practice
The use of the Accordion device in PCNL can help to decrease operative time, decrease morbidity by inhibiting stone fragments from entering the ureter, and increase the stonefree rate from PCNL. When the Accordion was used, the decreased concern for migrated stone fragments expedited ureteral catheter or stent removal. Based on our initial experience, we recommend the 10-mm device for this purpose, because it provides better occlusion and entrapment, especially in dilated collecting systems and ureters. We also recommend deployment in the proximal ureter just below the UPJ to prevent inadvertent forward displacement of the device into the renal pelvis, because this could then result in fragments "slipping" past the device and into the ureter.
The cost of the Accordion device is approximately $300, which is slightly higher than the price for a stone basket at our institution. The Accordion may be used with a safety wire, and we have used the Accordion with a 5F open-ended catheter in all cases.
Other devices, such as the stone cone and ureteral occlusion balloon, have been used by our center and others to prevent stone migration during PCNL. In our experience these devices did not provide reliable results. The stone cone usually does not occlude the ureter, especially if the ureter is dilated, and also moves with respiration. If placed in the ureter, the occlusion balloon can cause mucosal injury or ureteral tears. If placed just above the UPJ, the occlusion balloon moves with respiration and does not provide an adequate seal, thereby permitting antegrade migration of stone fragments.
Antegrade stone fragment migration is a problem, in our experience, without use of the Accordion device. While we
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FIG. 4.
Accordion™ device deployed at the ureteropelvic junction that prevents antegrade migration of large stone fragment. were able to have nearly 100% patients stone-free in both groups in our study, this necessitated increased use of fluoroscopy, ureteroscopy, and increased mean operative time to identify stone fragments in the ureter in group 2.
Second looks are not performed routinely in our center, because every effort is made at the primary procedure, including the use of flexible cystoscopy and ureteroscopy, to remove all fragments, even the tiniest of fragments. Every calix is inspected thoroughly. This process is time consuming but necessary to achieve stone-free status, and also affords us the ability to perform tubeless surgery, because no second look is necessary.
The Accordion device has been an invaluable addition to our routine, because we now have increased security that no fragments escape in antegrade fashion via the ureter. In this manner, we have minimized extra operative time, repair costs, and surgeon fatigue associated with flexible ureteroscopic evaluation and stone retrieval at the end of the procedure.
In addition, we were able to target larger staghorn calculi in group 1 with use of the Accordion than in group 2 without use of the Accordion device. Fewer postoperative ureteral stents were needed after the procedure in group 1 than in group 2 in various subpopulations. Perhaps with a larger sample size in the future, we may show a statistically significant difference between groups in terms of tubeless procedures and postoperative stent usage.
When excluding patients with UPJ obstruction and ureteral stricture, there was less need for a postoperative ureteral stent when the Accordion was used in contrast to the group without Accordion use. Length of stay was statistically similar between the two groups despite the greater number of complex cases in group 1 and two patients in this group who had prolonged hospital stays for medical reasons (autosomal dominant hypocalcemia workup, poor nutrition).
Conclusions
We have found this new stone entrapment device easy to insert and deploy. Our results suggest that the device successfully prevents antegrade stone fragment migration during percutaneous nephrolithotomy, reduces the use of ureteral stents and operative time, facilitates tubeless procedures, permits targeting larger stones, and should be considered as an invaluable tool for this procedure.
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